Brief: Harvard Bioscience Announces Third Quarter 2021 Financial Results
03/11/2021 12:19
Nov 3 (Reuters) - Harvard Bioscience Inc HBIO.O :
* HARVARD BIOSCIENCE ANNOUNCES THIRD QUARTER 2021 FINANCIAL
RESULTS
* HARVARD BIOSCIENCE INC - QTRLY REVENUE $29.7 MILLION
VERSUS $24
MILLION
* HARVARD BIOSCIENCE INC - QTRLY ADJUSTED EPS $0.06
* HARVARD BIOSCIENCE INC - EXPECTS REVENUE GROWTH OF 15-17%
FOR
2021 UP FROM 12-15%
Source text for Eikon: ID:nGNXxrx8m
Further company coverage: HBIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Harvard Bioscience
See all newsBrief: Harvard Bioscience Announces Creation Of Scientific Advisory Board
Harvard Bioscience Inc reports results for the quarter ended June 30 - Earnings Summary
Harvard Bioscience Q2 revenue rises on telemetry demand, lifts 2026 outlook
Harvard Bioscience Inc expected to post a loss of 21 cents a share - Earnings Preview
Harvard Bioscience Q1 revenue falls, reaffirms 2026 guidance